Combined treatment of prednisolone and angiotensin II receptor blocker in IgA nephropathy.

被引：0
|
作者：
Ihm, CG
Lee, SH
Lee, SH
Kim, YH
Lee, T
Kim, MJ
机构：
[1] Kyung Hee Univ, Coll Med, Seoul, South Korea
[2] InJe Univ, Coll Med, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：752A / 752A
页数：1
相关论文
共 50 条
  • [31] Angiotensin II Type-2 blockade in radiation nephropathy.
    Cohen, EP
    Fish, BL
    Moulder, JE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 412A - 412A
  • [32] Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: An emerging paradigm in diabetic nephropathy A systematic review
    Mavrakanas, Thomas A.
    Gariani, Karim
    Martin, Pierre-Yves
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (02) : 173 - 176
  • [33] Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1
    Lai, KN
    Chan, LYY
    Tang, SCW
    Tsang, AWL
    Li, FFK
    Lam, MF
    Lui, SL
    Leung, JCK
    KIDNEY INTERNATIONAL, 2004, 66 (04) : 1403 - 1416
  • [34] Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated mesangial cells and experimental diabetic nephropathy.
    Choi, SR
    Xu, ZG
    Yoon, HJ
    Choi, KH
    Ha, SK
    Lee, HY
    Han, DS
    Kang, SW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 296A - 296A
  • [35] Angiotensin II receptor blocker inhibits the expression of smad1 in diabetic nephropathy
    Mima, A
    Matsubara, T
    Abe, H
    Nagai, K
    Kanamori, H
    Sumi, E
    Iehara, N
    Fukatsu, A
    Kita, T
    Arai, H
    Doi, T
    DIABETES, 2005, 54 : A201 - A201
  • [36] ANGIOTENSIN II USE IN ANGIOTENSIN RECEPTOR BLOCKER OVERDOSE
    Goodwin, Erin
    Swenson, Colin
    Busse, Laurence
    Tendler, Rachel
    Sharifpour, Milad
    VanAcker, Cortney
    Daniels, Cara
    CRITICAL CARE MEDICINE, 2020, 48
  • [37] Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin receptor blocker (ARB) in pediatric patients with IgA nephropathy - Response
    Ohta, K
    CLINICAL NEPHROLOGY, 2006, 65 (03) : 227 - 228
  • [38] Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy
    Moulder, JE
    Fish, BL
    Cohen, EP
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1998, 73 (04) : 415 - 421
  • [39] A randomized control study of mycophenolate mofetil treatment in severe IgA nephropathy.
    Chen, XM
    Chen, P
    Cai, GY
    Wu, J
    Cui, Y
    Zhang, YP
    Liu, SW
    Li, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 14A - 14A
  • [40] Renal angiotensin II upregulation and myofibroblast activation in human membranous nephropathy.
    Mezzano, SA
    Aros, C
    Droguett, A
    Burgos, EM
    Ardiles, L
    Flores, C
    Carpio, D
    Vio, CP
    Ruiz-Ortega, M
    Egido, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 589A - 589A
12345